COMP is also found to be highly expressed in tumor tissues, such as hepatocellular carcinoma [93], colon cancer [23], and breast cancer [94], and is often related to a high recurrence rate and low survival rate in cancer patients, serving as an independent prognostic biomarker (Figure 2) [94]. This evidence concerns the gene COMP and breast cancer.